TAP1 and neoplasm: Even though TAP-independent antigens can be presented by TAP1-positive or TAP-negative tumor cells, failure of the cells to efficiently induce a large population of tumor-antigen specific CD8+ T-cell effectors may be a major reason limiting efficacy of antitumor immunity.